Scilex Holding (SCLXW) Non-Current Debt (2021 - 2025)

Scilex Holding (SCLXW) recorded quarterly Non-Current Debt of $22.5 million in Q4 2025, up 2560.36% quarter-over-quarter from $845000.0 in Q4 2024, and up 2560.36% on a YoY basis from $845000.0 in Q4 2024.

Scilex Holding (SCLXW) Non-Current Debt (2021 - 2025) Analysis & Trends

Scilex Holding's Non-Current Debt history runs 5 years deep, the most recent figure standing at $22.5 million for Q4 2025.

  • In Q4 2025, Non-Current Debt rose 2560.36% year-over-year to $22.5 million; the TTM figure through Dec 2025 stood at $22.5 million (up 2560.36% YoY), while the FY2025 annual figure was $22.5 million, up 2560.36% from the prior year.
  • Non-Current Debt was $22.5 million for Q4 2025 at Scilex Holding, up from $845000.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $72.0 million in Q4 2021 to a low of $845000.0 in Q4 2024.
  • Historically, Non-Current Debt has averaged $18.4 million across 5 years, with a median of $15.3 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Debt tumbled 95.04% in 2024, then jumped 2560.36% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $72.0 million in 2021, then tumbled by 95.87% to $3.0 million in 2022, then surged by 473.35% to $17.0 million in 2023, then sank by 95.04% to $845000.0 in 2024, then surged by 2560.36% to $22.5 million in 2025.
  • The last three Non-Current Debt figures came in at $22.5 million (Q4 2025), $845000.0 (Q4 2024), and $14.3 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -18.89 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 39.37 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 37.53 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 64.53 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 46.67 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 51.89 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 20.86 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 60.57 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 42.15 Bn
10 Scilex Holding - - 4.15 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 22.48 Mn
Dec 31, 2025 22.48 Mn
Dec 31, 2024 845,000.00
Dec 31, 2024 845,000.00
Sep 30, 2024 14.33 Mn
Sep 30, 2024 14.33 Mn
Jun 30, 2024 29.03 Mn
Jun 30, 2024 29.03 Mn
Mar 31, 2024 16.32 Mn
Mar 31, 2024 16.32 Mn
Dec 31, 2023 17.04 Mn
Dec 31, 2023 17.04 Mn
Sep 30, 2023 6.93 Mn
Sep 30, 2023 6.93 Mn
Sep 30, 2022 2.97 Mn
Sep 30, 2022 2.97 Mn
Jun 30, 2022 2.00 Mn
Jun 30, 2022 2.00 Mn
Dec 31, 2021 72.04 Mn
Dec 31, 2021 72.04 Mn